Skip to main
LEXX

Lexaria Bioscience (LEXX) Earnings Dates & Reports

Lexaria Bioscience (LEXX) Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.08
Actual EPS-$0.07
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lexaria Bioscience (LEXX) Earnings per Share (EPS) History

Signup for full access
Browse free

Lexaria Bioscience (LEXX) Latest Earnings

The value each LEXX share was expected to gain vs. the value each share gained.

Lexaria Bioscience (LEXX) reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.07. This exceeded analysts' expectations of -$0.08 by 12.50%, marking a Beat.

For comparison, Lexaria Bioscience reported EPS of -$0.16 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.08.

Lexaria Bioscience (LEXX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.08
Q1 2026
-$0.08-$0.07-12.50%
Q4 2025
-$0.16-$0.13-18.75%
Q3 2025
-$0.15-$0.21+40.00%
Q2 2025
-$0.16-$0.15-6.25%
View all

Lexaria Bioscience (LEXX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Lexaria Bioscience’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Lexaria Bioscience (LEXX) Earnings FAQs

Lexaria Bioscience (LEXX) last reported earnings on Jan 13, 2026 for Q1 2026, posting an EPS of -$0.07, which Beat the estimate of -$0.08 by 12.50%.

For Q1 2026, Lexaria Bioscience (LEXX) reported an EPS of -$0.07, exceeding analysts' estimate of -$0.08 by 12.50%.

For Q1 2026, Lexaria Bioscience (LEXX) Beat expectations with an actual EPS of -$0.07 vs. an estimated EPS of -$0.08.

Following the last earnings report on Jan 13, 2026, Lexaria Bioscience (LEXX)'s stock price moved — from — to —.

The next Lexaria Bioscience (LEXX) earnings call is scheduled for Apr. 13, 2026, where executives will discuss financial results and outlook.

Lexaria Bioscience (LEXX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.